The United States is widely considered the premier country for pharmaceutical and biotechnology companies due to its massive domestic healthcare market, robust venture capital funding, world-class research universities, and a regulatory framework through the FDA that encourages rapid drug innovation. Other nations like Switzerland, the United Kingdom, Germany, and Japan also possess exceptionally strong pharmaceutical sectors, highly skilled workforces, and advanced intellectual property protection frameworks.